SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-157164
Filing Date
2017-05-04
Accepted
2017-05-04 06:15:32
Documents
53
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d375100d10q.htm 10-Q 808545
2 EX-31.1 d375100dex311.htm EX-31.1 9271
3 EX-31.2 d375100dex312.htm EX-31.2 9282
4 EX-32.1 d375100dex321.htm EX-32.1 3082
5 EX-32.2 d375100dex322.htm EX-32.2 3241
  Complete submission text file 0001193125-17-157164.txt   4342035

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aveo-20170331.xml EX-101.INS 741927
7 XBRL TAXONOMY EXTENSION SCHEMA aveo-20170331.xsd EX-101.SCH 49121
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aveo-20170331_cal.xml EX-101.CAL 52550
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aveo-20170331_def.xml EX-101.DEF 166487
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20170331_lab.xml EX-101.LAB 421856
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20170331_pre.xml EX-101.PRE 288956
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617- 531-2130
AVEO PHARMACEUTICALS INC (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34655 | Film No.: 17811711
SIC: 2834 Pharmaceutical Preparations